Searched for
IVAX
Ranbaxy forfeits 180 days exclusivity for generic NexiumRanbaxy said USFDA has determined that it has forfeited its 180-day exclusivity to sell generic version of digestive disorder medicine Nexi...- Sun Pharma-Ranbaxy deal: We will guide Ranbaxy, says Dilip ShanghviShanghvi started his entrepreneurial dreams with a loan of Rs 10,000 from his father. It’s that same instinct that’s needed at Ranbaxy now,...
- I don’t have targets for acquisitions: Dilip ShanghviIf you have targets for acquisitions you end up making compromises in terms of valuations and you buy things because you have a target and ...
- TEVA TO buy local unit for Rs 400 crThe world’s largest generic drug manufacturer Teva may be close to acquiring domestic company Saraca Labs’ manufacturing plant in Hyderabad...
- Mylan Labs may use Indian platform for global pharma playWith the acquisition of Merck KGaA’s generic business by Mylan Laboratories, India is set to become a major manufacturing hub for the US dr...
- Cipla, PEs team up for Merck's bizRanbaxy Lab, Teva Corp, Actavis and Mylan are among the cos short listed in the first round.
- Merck Generics valuation to be hit as Duoneb patent endsMerck Generics' lucrative US subsidiary Dey, a specialty pharmaceutical company focused on the development of new drug delivery systems for...
- Cos exit generics for core focusAs international generics drug markets reel under increasing pricing pressure and ever-rising competition, big pharma companies are selling...
- Merck buy may give Ranbaxy access to US, Europe marketsRanbaxy Labs has joined the race with global pharma companies such as Teva, Novartis and Sanofi-Aventis for acquiring the global generic dr...
- Ranbaxy may pop Merck pillRanbaxy Labs has entered the race for acquiring the global generic drug business of Merck KGaA.
- Safe & steady strategy gives Cipla lead over RanbaxySome years ago, investors were hooked to Ranbaxy Labs’ growth story and the many earnings triggers that lay ahead.
Load More- TEVA TO buy local unit for Rs 400 cr
